Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-11,000
Closed -$168K 201
2023
Q1
$168K Sell
11,000
-11,178
-50% -$146K 0.01% 185
2022
Q4
$282K Buy
+22,178
New +$200K 0.02% 135

Other funds holding ETNB

683 Capital Management's ETNB Position: Q2 2023 in Review

683 Capital Management sold out of 89bio (ETNB) in Q2 2023, closing a stake of 11,000 shares — an estimated $168K sold.

683 Capital Management first reported a position in ETNB in Q4 2022 and held it in 2 quarters. The position peaked at $282K in Q4 2022. 157 funds tracked by Wall St. Rank hold ETNB as of Q2 2023.

  • 683 Capital Management reported no remaining 89bio position as of Q2 2023 after selling out during the quarter.
  • 683 Capital Management sold 11,000 89bio shares in Q2 2023, an estimated $168K.
  • 683 Capital Management first reported a position in 89bio in Q4 2022 and held it in 2 quarters.
  • 683 Capital Management's 89bio position peaked at $282K in Q4 2022.
  • 157 funds tracked by Wall St. Rank held 89bio as of Q2 2023.

Based on 683 Capital Management's 13F filing for Q2 2023, filed 14 Aug 2023.